We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-2.06%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$268M
AUM Growth
-$59.5M
Cap. Flow
-$50.9M
Cap. Flow %
-19%
Top 10 Hldgs %
44.52%
Holding
92
New
17
Increased
19
Reduced
32
Closed
23

Top Buys

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$9.9M
2
ABT icon
Abbott
ABT
+$8.03M
3
JNJ icon
Johnson & Johnson
JNJ
+$7.21M
4
BDX icon
Becton Dickinson
BDX
+$6.5M
5
ELV icon
Elevance Health
ELV
+$5.07M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$9.44M
2
DHR icon
Danaher
DHR
+$9.11M
3
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$7.69M
4
BBH icon
VanEck Biotech ETF
BBH
+$6.22M
5
SBRA icon
Sabra Healthcare REIT
SBRA
+$6.16M

Sector Composition

Rank Sector Weight
1 Healthcare 93.35%
2 Real Estate 1.88%
3 Financials 1.53%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
26
Cigna
CI
$73.7B
$3.46M 1.29%
20,600
+18,600
+930% +$3.61M
EVHC
27
DELISTED
Envision Healthcare Holdings Inc
EVHC
$3.16M 1.18%
82,174
-114,000
-58% -$4.26M
CELG
28
DELISTED
Celgene Corp
CELG
$2.85M 1.07%
32,000
-5,800
-15% -$557K
TVTY
29
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$2.41M 0.9%
60,819
-197,938
-76% -$7.69M
PTLA
30
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.33M 0.87%
71,500
-36,100
-34% -$1.58M
WMGI
31
DELISTED
Wright Medical Group Inc
WMGI
$2.24M 0.84%
113,072
-192,128
-63% -$4.12M
KA
32
DELISTED
Kineta, Inc. Common Stock
KA
$2.24M 0.84%
3,372
-92
-3% -$55.5K
BAX icon
33
Baxter International
BAX
$13.5B
$2.17M 0.81%
33,349
-16,900
-34% -$1.14M
HRC
34
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.12M 0.79%
24,400
-41,800
-63% -$3.57M
DHR icon
35
Danaher
DHR
$137B
$2.08M 0.78%
23,987
-104,114
-81% -$9.11M
OXFD
36
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.06M 0.77%
165,169
-405,256
-71% -$4.93M
FOLD
37
DELISTED
Amicus Therapeutics
FOLD
$1.91M 0.71%
127,000
-79,400
-38% -$1.21M
MASI
38
DELISTED
Masimo
MASI
$1.84M 0.69%
+20,900
New +$1.82M
CLVS
39
DELISTED
Clovis Oncology, Inc.
CLVS
$1.75M 0.65%
33,100
-34,550
-51% -$2.02M
PBYI icon
40
Puma Biotechnology
PBYI
$404M
$1.68M 0.63%
24,700
-5,200
-17% -$389K
MCK icon
41
McKesson
MCK
$100B
$1.62M 0.61%
11,523
-60,577
-84% -$9.44M
INCY icon
42
Incyte
INCY
$24.2B
$1.62M 0.6%
19,420
+12,000
+162% +$1.08M
FATE icon
43
Fate Therapeutics
FATE
$286M
$1.52M 0.57%
155,344
-401,335
-72% -$3.84M
PPH icon
44
VanEck Pharmaceutical ETF
PPH
$959M
$1.45M 0.54%
+25,500
New +$1.52M
RVTY icon
45
Revvity
RVTY
$12.6B
$1.44M 0.54%
19,041
+9,636
+102% +$744K
CAH icon
46
Cardinal Health
CAH
$53.9B
$1.41M 0.53%
22,542
-79,229
-78% -$5.44M
BHC icon
47
Bausch Health
BHC
$2.58B
$1.36M 0.51%
+85,200
New +$1.59M
A icon
48
Agilent Technologies
A
$39.1B
$1.34M 0.5%
+20,000
New +$1.4M
DGX icon
49
Quest Diagnostics
DGX
$25.7B
$1.3M 0.49%
+13,000
New +$1.33M
ARRY
50
DELISTED
Array Biopharma Inc
ARRY
$1.17M 0.44%
71,400
+20,800
+41% +$333K
1
2
3 4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Endurant Capital Management held 92 positions worth $268M, down 18% from $327M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Endurant Capital Management withdrew a net $50.9M in Q1 2018, closing 23 positions and reducing 32 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $6.22M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 86% a quarter earlier, followed by Real Estate and Financials.

Against the trend, Endurant Capital Management opened a new position in Universal Health Services worth $9.88M.

  • Endurant Capital Management's largest Q1 2018 buy was Universal Health Services: 83,400 shares worth $9.88M.
  • Endurant Capital Management added most to Abbott in Q1 2018, an estimated $8.03M increase.
  • Endurant Capital Management's biggest Q1 2018 reduction was McKesson, cutting an estimated $9.44M.
  • Endurant Capital Management fully exited VanEck Biotech ETF in Q1 2018, selling an estimated $6.22M.
  • Endurant Capital Management's ten largest holdings make up 45% of its $268M portfolio in Q1 2018.
  • Endurant Capital Management opened 17 new positions and closed 23 in Q1 2018.
  • Endurant Capital Management's portfolio value fell 18% quarter-over-quarter to $268M.

Based on Endurant Capital Management's 13F filing for Q1 2018, filed 15 May 2018.